114 related articles for article (PubMed ID: 32196587)
1. Clinical significance of CA 19.9 and LINC01197 in pancreatic cancer.
Jia YH; Zheng WW; Ye ZH
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2358-2367. PubMed ID: 32196587
[TBL] [Abstract][Full Text] [Related]
2. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling.
Ling J; Wang F; Liu C; Dong X; Xue Y; Jia X; Song W; Li Q
J Exp Clin Cancer Res; 2019 Apr; 38(1):179. PubMed ID: 31027497
[TBL] [Abstract][Full Text] [Related]
3. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
5. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance.
Jia F; Liu M; Li X; Zhang F; Yue S; Liu J
World J Surg Oncol; 2019 Sep; 17(1):163. PubMed ID: 31526392
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer.
Peng W; Jiang A
Biomed Pharmacother; 2016 Oct; 83():712-717. PubMed ID: 27470572
[TBL] [Abstract][Full Text] [Related]
7. Hsa-miR-4730 as a new and potential diagnostic and prognostic indicators for pancreatic cancer.
Yang W; Ju HY; Tian XF
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8801-8811. PubMed ID: 32964968
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
9. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer.
Chen P; Wan D; Zheng D; Zheng Q; Wu F; Zhi Q
Biomed Pharmacother; 2016 Oct; 83():1220-1226. PubMed ID: 27562722
[TBL] [Abstract][Full Text] [Related]
11. Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer.
Zhao YP; Zhou PT; Ji WP; Wang H; Fang M; Wang MM; Yin YP; Jin G; Gao CF
Clin Exp Med; 2017 Feb; 17(1):9-18. PubMed ID: 26714469
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers.
Wang Y; Li Z; Zheng S; Zhou Y; Zhao L; Ye H; Zhao X; Gao W; Fu Z; Zhou Q; Liu Y; Chen R
Oncotarget; 2015 Nov; 6(34):35684-98. PubMed ID: 26447755
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance and Diagnostic Value of Overexpressed lncRNA PVT1 in Colorectal Cancer.
Pan X; Cheng R; Zhu X; Cai F; Zheng G; Li J; Gao C
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850702
[TBL] [Abstract][Full Text] [Related]
14. A Novel and Robust Long Noncoding RNA Panel to Predict the Prognosis of Pancreatic Cancer.
Li M; Li H; Chen Q; Wu W; Chen X; Ran L; Si G; Tan X
DNA Cell Biol; 2020 Jul; 39(7):1282-1289. PubMed ID: 32522048
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
[TBL] [Abstract][Full Text] [Related]
16. Elevated Transient Receptor Potential Melastatin 8 (TRPM8) Expression Is Correlated with Poor Prognosis in Pancreatic Cancer.
Du JD; Zheng X; Chen YL; Huang ZQ; Cai SW; Jiao HB; Zhu ZM; Hu B
Med Sci Monit; 2018 Jun; 24():3720-3725. PubMed ID: 29860264
[TBL] [Abstract][Full Text] [Related]
17. Potential diagnostic and prognostic value of plasma long noncoding RNA LINC00086 and miR-214 expression in gastric cancer.
Ji B; Huang Y; Gu T; Zhang L; Li G; Zhang C
Cancer Biomark; 2019; 24(2):249-255. PubMed ID: 30689553
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer.
Peng W; Gao W; Feng J
Med Oncol; 2014 Dec; 31(12):346. PubMed ID: 25412939
[TBL] [Abstract][Full Text] [Related]
19. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
20. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
Li W; Li N; Kang X; Shi K
Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
